An infective aetiology for vulval lichen sclerosus re-addressed

Clinical and Experimental Dermatology

Volumn 24, Issue 6, 1999, Pages 479-483

  Farrell, A M ^a,b   Millard, P R ^a   Schomberg, K H ^a   Wojnarowska, F ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; CLINICAL ARTICLE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; LICHEN SCLEROSUS ET ATROPHICUS; MAST CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; VULVA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; VULVAR DISEASES;

EID: 0033405318     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00538.x     Document Type: Article

References (34)

1. Friedrich EG, MacLaren NK. Genetic aspects of vulvar lichen sclerosus. Am J Obstet Gynecol 1984; 150: 161-5.
2. Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnaroska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197-203.
3. Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity, a study of 350 women. Br J Dermatol 1988; 118: 41-6.
4. Aberer E, Neumann R, Lubec G. Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms. Acta Dermatol Venereol (Stockh) 1987; 67: 62-5.
5. Åsbrink E, Hovmark A, Olsson I. Clinical manifestations of acrodermatitis chronic atrophicans in 50 Swedish patients. Zbl Bakt Hyg 1986; 263: 253-61.
6. Uitto J, Santz Cruz DJ, Bauer EA, Eisen AZ. Morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol 1980; 3: 271-9.
7. Aberer E, Klade H, Stanek G, Gebhart W. Borrelia burgdorferi and different types of morphea. Dermatologica 1991; 182: 145-54.
8. Neubert U, Gertmeier J, Meurreu M et al. Spirochaetal antibodies in morphea. J Invest Dermatol 1985; 86: 336-7.
9. Takahashi S, Niizeki H, Fukuda T et al. Anti-Borrelia anti-bodies in the patients with localized scleroderma. Jpn J Dermatol 1995; 105: 1301-7.
10. Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 1990; 12: 357-62.
11. Cantwell AR. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea and lichen sclerosus et alrophicus. Int J Dermatol 1984; 23: 45-52.
12. Lupoli S, Cutler SJ, Stephens CO, Wright DJM, Black CM. Lyme disease and localized scleroderma - no evidence for a common aetiology (Letter). Br J Rheumatol 1991; 30: 154-6.
13. Hoesly JM, Mertz LE, Winkelmann RK. Localised scleroderma (morphea) and antibody to Borrelia burgdorferi. J Am Acad Dermatol 1987; 17: 455-8.
14. Vaillant L, Goudeau A. Localized scleroderma is not a Borrelia burgdorferi infection in France (Letter). Dermatology 1992; 184: 286-8.
15. Pinazo Canales I, Betlloch MI, Mestre Bauza F et al. Determinacion de anticuerpos frente a Borrelia burgdorferi en pacientes con morfea, liquen escleroso y atrofico y eritema cronico migrans. Rev Clin Esp 1990; 186: 320-3.
16. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen scelrosus et atrophicus. Am J Dermatopathol 1987; 9: 374-9.
17. Raguin G, Boisnic S, Souteyrand P et al. No evidence for a spirochaetal origin of localized scleroderma. Br J Dermatol 1992; 127: 218-20.
18. Aberer E, Stanek G, Ertl M, Neumann R. Evidence for spirochetal origin of circumscribed sceleroderma (morphea). Acta Dermatol Venereol 1987; 67: 225-31.
19. Weber K, Preac-Mursic V, Reimers CD. Spirochetes isolated from two patients with morphea. Infection 1988; 16: 25-6.
20. Levell NJ, Leslie TA, Cann KJ et al. Detection of Borrelia buradorferi DNA in morphoea and lichen sclerosus et atrophicus with the polymerase chain reaction. Br J Dermatol 1994; 131: 436.
21. Buechner SA, Winkelmann RK, Lautenschlager S, Gilli L, Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection. J Am Acad Dermatol 1993; 29: 190-6.
22. Breier F, Klade H, Stanek G et al. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br J Dermatol 1996; 134: 285-91.
23. Schempp C, Hubertus B, Lange R, Kölmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993; 100: 717-20.
24. Dillon WI, Ghassan MS, Fivenson DP. Borrelia burgdorferi DNA in undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermutol 1995; 33: 617-20.
25. Meis J, Koopman R, van Bergen B, Pool G, Melchers W. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localised scleroderma (morphea). Arch Dermatol 1993; 129: 386-7.
26. Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol 1995; 104: 23-6.
27. Ranki A, Aavik E, Peterson P, Schauman K, Nurmilaakso P. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol 1994; 102: 339-45.
28. Fan W, Leonardi CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized sleroderma (morphea). J Am Acad Dermatol 1995; 33: 682-4.
29. Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L. No evidence for Borreilia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. Acta Dermatol Venereol (Stockh) 1997; 77: 299-304.
30. Fujiwara H, Fujiwara K, Hashimoto K et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzzelli) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not US patients. Arch Dermatol 1997; 133:41-4.
31. Granter SR, Barnhill RL, Duray PH. Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol 1996; 118: 465-73.
32. Wuerthele-Caspé V, Alexander-Jackson E, Anderson JA, Hillier J, Allen RM, Smith LW. Cultural properties and pathogenicity of certain microorganisms obtained form various proliferative and neoplastic diseases. Am J Med Sci 1950; 220: 638-48.
33. 3 Delmotte N, van der Meiren L. Recherches bacteriologiques et histologiques concernant la sclérodermie. Dermatologica 1953; 107: 177-82.
34. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998; 138: 399-406.